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High Basal Expression of Interferon-Stimulated Genes in
Human Bronchial Epithelial (BEAS-2B) Cells Contributes
to Influenza A Virus Resistance
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Abstract
Respiratory epithelial cells play a key role in influenza A virus (IAV) pathogenesis and host innate response. Transformed
human respiratory cell lines are widely used in the study of IAV2host interactions due to their relative convenience, and
inherent difficulties in working with primary cells. Transformed cells, however, may have altered susceptibility to virus
infection. Proper characterization of different respiratory cell types in their responses to IAV infection is therefore needed to
ensure that the cell line chosen will provide results that are of relevance in vivo. We compared replication kinetics of human
H1N1 (A/USSR/77) IAVs in normal primary human bronchial epithelial (NHBE) and two commonly used respiratory epithelial
cell lines namely BEAS-2B and A549 cells. We found that IAV replication was distinctly poor in BEAS-2B cells in comparison
with NHBE, A549 and Madin-Darby canine kidney (MDCK) cells. IAV resistance in BEAS-2B cells was accompanied by an
activated antiviral state with high basal expression of interferon (IFN) regulatory factor-7 (IRF-7), stimulator of IFN genes
(STING) and IFN stimulated genes (ISGs). Treatment of BEAS-2B cells with a pan-Janus-activated-kinase (JAK) inhibitor
decreased IRF-7 and ISG expression and resulted in increased IAV replication. Therefore, the use of highly resistant BEAS-2B
cells in IAV infection may not reflect the cytopathogenicity of IAV in human epithelial cells in vivo.
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Introduction
Influenza A viruses (IAVs) infect a wide spectrum of avian and
mammalian hosts with a range of clinical manifestations from mild
or in-apparent infection to severe fatal disease. The dangerous
features of IAVs are their highly infectious nature, broad host
range, and their inherent nature to frequently mutate and/or
reassort from mixed infections, resulting in emergence of new
strains. Despite ongoing vaccination programmes, influenza is still
one of the leading causes of human deaths, with 3–5 million cases
of severe illness and up to 500,000 deaths each year (http://www.
who.int/mediacentre/factsheets/fs211/en/). IAVs have been
shown to readily overcome vaccine specificity and develop
resistance against the few available antiviral drugs such as
neuraminidase inhibitors [1].
While seasonal influenza virus infection typically causes
contagious respiratory disease in humans with relatively low
mortality rate, infections with some of the highly pathogenic avian
influenza (HPAI) viruses of the H5N1 subtype could cause up to
60% mortality [2]. The unusual severity of HPAI H5N1 virus
infections in humans has been attributed to hyperacute dysregu-
lation of pro-inflammatory cytokines and chemokines often
referred to as a ‘cytokine storm’ [3,4]. It has previously been
shown that pigs are inherently more resistant to HPAI H5N1 virus
infection than humans, with reduced infectious virus production
and pro-inflammatory response [5]. It is increasingly clear that
host responses critically contribute to the disparate clinical
outcomes of IAV infection.
Respiratory epithelial cells are the primary early targets of IAVs
and are key players in the host innate immune responses to IAV
infection. The first step in IAV infection is the attachment of viral
haemagglutinin (HA) to host cell sialic acid (SA) receptors [6].
Avian influenza viruses show preferential binding to SA receptors
linked to galactose with an alpha 2–3 linkage (SAa 2,3 Gal)
whereas classical human influenza viruses preferentially bind to
alpha 2,6 linked SA receptors (SAa 2,6 Gal) [7,8]. Human
respiratory epithelial cells express both alpha 2,3 and alpha 2,6
receptors [9] and are permissive to a range of avian and
mammalian influenza virus replication. Hence, respiratory
epithelial cells are important in the study of influenza virus2host
interactions.
As alternatives to primary normal human bronchial epithelial
(NHBE) cells, immortalised human respiratory cell lines are often
used as they are easily accessible, cost-effective and can be
propagated almost indefinitely. For example, adenovirus-12 SV40
transformed human bronchial epithelial cells (BEAS-2B) and
adenocarcinomic human alveolar basal epithelial cells (A549) are
two of the most common cell lines used in the study of IAV2host
interactions [10–12] and in infections with other respiratory
viruses such as human respiratory syncytial virus [13,14].
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Many immortalized cell lines such as Madin-Darby canine
kidney (MDCK), Vero and baby hamster kidney (BHK21) cells
are readily permissive to influenza virus replication and are also
widely used for in vitro virus infection studies. However, IAV
replication kinetics can vary depending on the virus strain and the
type of cell line. For example, MDCK cells support more rapid
growth of influenza viruses than Vero cells [15]. However little is
known about the differences in IAV replication between primary
human respiratory epithelial cells and cell lines. It has been shown
that antiviral response pathways are dysregulated in cancer cells
due to immortal transformation [16–18]. Therefore, there may be
differences in antiviral mechanisms between primary cells and
transformed cells that could result in differences in virus
replication and cellular responses to virus infection.
Consequently, it is likely that IAV replication kinetics and
cellular responses to virus infection could be different between
primary and immortalized respiratory cells. Proper characteriza-
tion, in particular of viral growth, in different respiratory cell types
is therefore needed to allow rational selection of the most
appropriate cells for addressing specific influenza research
questions.
Figure 1. BEAS-2B cells were considerably less permissive to influenza virus replication than MDCK cells. (A) MDCK and BEAS-2B cells
were infected with USSR H1N1 or H2N3 influenza viruses at 1.0 MOI (based on MDCK cells), and viral NP expression was determined at 6 h post-
infection (hpi). All MDCK cells were positive for viral NP at 6 hpi with (Aa) human H1N1 and (Ab) avian H2N3 viruses. (B) In contrast, few
corresponding virus positive BEAS-2B cells were found (Ba and Bb). Mock infected MDCK (Ac) and BEAS-2B (Bc) cells showed no staining. MDCK cells
and BEAS-2B cells were infected with H1N1 virus (dose equivalent to MOI 1.0 as per MDCK titration) to determine cellular expression of viral M gene
RNA, normalized to 18Sr RNA (C), PB1 protein expression at 9 and 24 hpi (D), and infectious virus output at 9, 24, 48 and 72 hpi (D). In BEAS-2B cells,
(C) viral M gene expression was much lower than MDCK cells, (D) little or no PB1 protein was detected (only detected faint bands for PB1 after
prolonged exposure for 20 min) and (E) less infectious progeny virus was produced over 72 h of infection. ** (p,0.01).
doi:10.1371/journal.pone.0109023.g001
BEAS2B Cells Resistant to Influenza Virus Infection
PLOS ONE | www.plosone.org 2 October 2014 | Volume 9 | Issue 10 | e109023
In order to characterize differences in virus replication between
human primary and transformed respiratory epithelial cells, we
compared virus replication and cellular responses to human H1N1
IAV infections in NHBE, BEAS-2B and A549 cells. We found that
BEAS-2B cells are highly resistant to avian and human IAV
infections in comparison with NHBE and A549 cells.
Materials and Methods
Cells and viruses
BEAS-2B (Sigma Aldrich) and NHBE (Lonza) cells were
cultured in bronchial epithelial growth medium (BEGM, Lonza)
at 37uC in an atmosphere of 5% CO2. A549 cells (ATCC CCL-
185) and MDCK cells were cultured in Dulbecco’s Modified
Eagle’s Medium (DMEM) supplemented with 100 units/ml
penicillin and 100 mg/ml streptomycin (Invitrogen), 10% fetal
bovine serum (FBS) and 0.3 g/l L-glutamine. A549 cells were
switched to BEGM 48 h before virus challenge.
A low pathogenicity avian influenza (LPAI) H2N3 virus (A/
mallard duck/England/7277/06) and a moderately pathogenic
human influenza H1N1 (A/USSR/77) virus were used. All viruses
were grown by allantoic inoculation of 10-day-old embryonated
hens’ eggs. Viruses were titrated in MDCK cells using an
immunocytochemical focus assay [19].
Virus infection of cells
At 80% confluence, cells were rinsed twice with phosphate
buffered saline (PBS) and infected with H1N1 or H2N3 IAVs at
multiplicity of infection (MOI) of 1.0, based on virus titration
values on MDCK cells, in infection medium comprising 2%
Ultroser G (Pall Biosepra, Portsmouth, UK), 500 ng/ml TPCK
trypsin (Sigma-Aldrich Ltd.) and antibiotics in Ham’s F12. At 2 h
incubation, cells were rinsed twice with PBS and fresh infection
medium added. Cells were further incubated for 4, 6 or 22 h. Cells
infected for 6 h were fixed in acetone: methanol (1:1) for 10 min
and were subjected to immunocytochemical staining using a
murine monoclonal antibody to influenza nucleoprotein (NP) as
previously described [5]. At 10 and 24 h post infection, culture
supernatants were collected for infectious virus titration on
MDCK cells as previously described [19]. Total RNA was
extracted using RNeasy plus kit (Qiagen) following the manufac-
turer’s instructions.
Influenza receptor detection
Influenza virus receptors on cultured cells were characterized
using FITC-labelled Sambucus nigra agglutinin (SNA) (Vector
Labs) for SAa 2,6 Gal, and biotinylated Maackia amurensis
agglutinin II (MAA II) (Vector Labs) for SAa 2,3 Gal in a
previously described lectin-cytochemical method [20].
Influenza PB1 protein expression
Infected cells were lysed using RIPA lysis buffer (Santa Cruz)
and cellular proteins were separated on a Tris-glycine gel and
blotted onto polyvinylidene difluoride (PVDF) membrane. Viral
polymerase basic 1(PB1) protein expression was detected by
western blot analysis using a goat polyclonal primary anti-PB1
antibody (Santa Cruz), followed by donkey anti-goat IgG-
horseradish peroxidase (IgG-HRP) (Santa Cruz), and subsequently
visualized by standard enhanced chemiluminescence reaction
ECL detection kit (Amersham Life Science Ltd).
Viral and host gene expression
Quantification of expression of viral and host genes based on
cDNA converted from total RNA (Superscript III first strand
cDNA synthesis kit, Invitrogen) was performed on a LightCycler-
96 (Roche, Mannheim, Germany) using the SYBR green or
TaqMan method. Primers and probe used for detecting influenza
matrix (M) gene expression were as previously described [21].
Primers for the expression analysis of IL-6, IFNb, and Mx1 were
as described in Nelli et al. (2012) [22]. Predesigned primers
Figure 2. Similar distribution of human and avian influenza virus receptors on BEAS-2B and MDCK cells. Human (SAa2,6-Gal [green])
and avian (SAa2,3-Gal [red]) virus receptors were detected on (A) BEAS-2B and (B) MDCK cells by lectins SNA and MAA II, respectively. Co-expression of
both receptors was found in BEAS-2B and MDCK cells. Negative controls were performed without lectin incubation.
doi:10.1371/journal.pone.0109023.g002
BEAS2B Cells Resistant to Influenza Virus Infection
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(KiCqStart SYBR Green Primers) for expression analysis of
ISG15, STING, IRF-7 and IRF-3 were purchased from Sigma
Aldrich. Other primer sequences are as follows: interferon beta
(IFN-b) sense: 59- ACCTCCGAAACTGAAGATCTCCTA-39,
antisense: 59- TGCTGGTTGAAGAATGCTTGA-39; ISG15
sense: 59- AGATCACCCAGAAGATCG-39, antisense: 59-TG-
TTATTCCTCACCAGGATG-39; STING sense: 59-CTATTTC-
TACTACTCCCTCCC-39antisense: 59- CGCAGATATCCGA-
TGTAATATG-39; Mx1 sense: 59- TTCTGGGTCGGAGGC-
TACAG-39, antisense: 59- TGGATGGCGGCGTTCT-39; IRF-7
sense: 59- TCTTCTTCCAAGAGCTGG-39, antisense: 59- CT-
ATCCAGGGAAGACACAC-39; IL-6 sense: 59- GGTA-
CATCCTCGACGGCATCT-39, antisense: 59- GTGCCTCTT-
TGCTGCTTTCAC-39. Data were normalized to 18S rRNA
expression using a relative standard curve method [23].
JAK inhibition
BEAS-2B cells were treated with 2.5 or 5.0 mM concentration of
pyridine 6 (P6) [2-(1,1-dimethylethyl)-9-fluoro-3,6-dihydro-7H-
benz[h]-imidaz[4,5-f]isoquinolin-7-one, Calbiochem], a pan-Ja-
nus-activated-kinase (JAK) inhibitor [24]. JAK inhibitor P6 was
dissolved in DMSO. Following pre-treatment of cells with different
concentrations of P6 or corresponding amounts of DMSO as
controls for 24 h, medium was removed and cells were rinsed with
PBS before infecting with H1N1 influenza virus at MOI of 1.0,
based on viral titration values on MDCK cells. Cells were
immunostained for viral NP at 6 h of infection. At 24 h infection,
ISG expression, influenza viral M gene was quantified from total
RNA, and progeny virus output in culture media was determined
by immunocytochemical focus assays on MDCK cells.
Figure 3. BEAS-2B cells were more resistant than human primary NHBE cells and human A549 cells to human H1N1 (A) and avian
H2N3 (B) influenza virus. Cells were infected with the respective virus at a dose that was equivalent to 1.0 MOI in MDCK cells. For both viruses, few
BEAS-2B cells (a), most NHBE cells (b), and virtually all A549 cells (c) were positive for viral NP at 6 h of infection. At 24 h of infection with human
H1N1 virus (C and D), M gene expression (C) and infectious virus production (D) from BEAS-2B cells were significantly less than corresponding NHBE
and A549 cells, with A549 cells showing the highest M gene expression (C) and infectious virus production (D). **p,0.01.
doi:10.1371/journal.pone.0109023.g003
BEAS2B Cells Resistant to Influenza Virus Infection
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Figure 4. BEAS-2B cells showed greater accumulation of avian H2N3 virus than human H1N1 virus in prolonged cultures. At 6h of
infection with H1N1 (A) and H2N3 (B) virus (at MOI 1.0 based on MDCK cells titration), there was little difference in virus accumulation as determined
by viral NP detection. However, over 72h of H2N3 virus infection, there was progressive increase in NP intensity and number of infected cells (B). Such
increases were barely detected in H1N1 virus infected BEAS-2B cells (A).
doi:10.1371/journal.pone.0109023.g004
Figure 5. Resistance of BEAS-2B to influenza virus infection associated with high basal expression of IRF-7 and several ISGs. The
basal expression of a selection of genes associated with antiviral function was determined in the three human epithelial cell types (BEAS-2B, NHBE
and A549 cells). In BEAS-2B cells, (A) basal IRF-7 expression was significantly higher than the other two cell types (p,0.05). Basal basal expression of
(D) STING (E) ISG15 and (F) Mx1 in BEAS-2B cells was also significantly higher (p,0.05) than in NHBE and A549 cells. Data normalized to 18S rRNA
expression. Data points represent mean of 3 biological replicates. Error bar = SEM, *p,0.05.
doi:10.1371/journal.pone.0109023.g005
BEAS2B Cells Resistant to Influenza Virus Infection
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Statistical analysis
Statistical analyses for quantitative reverse transcriptionPCR
(qRT-PCR) data were carried out using Relative Expression
Software Tool (REST, Qiagen) [25]. Statistical analysis of
infectious virus titration data was performed by a two-sample t
test using Minitab software version 16 (16.2.2.).
Results
BEAS-2B cells were highly resistant to influenza virus
infection relative to MDCK cells
BEAS-2B and MDCK cells were infected with USSR H1N1
and LPAI H2N3 IAVs at MOI of 1.0, based on viral titration
values on MDCK cells. MDCK cells infected for 6 h with human
H1N1 (Figure 1Aa) or avian H2N3 (Figure 1Ab) IAVs showed
100% detection of viral NP. In sharp contrast, less than 5% of
BEAS-2B cells were positive for viral NP (Figure 1B).
To evaluate the kinetics of virus replication, cellular expression
of viral M gene RNA, viral PB1 protein and infectious virus
production were compared between H1N1 virus-infected MDCK
and BEAS-2B cells. At 24 h infection, M gene expression was
significantly higher (p,0.05) in MDCK cells than in BEAS-2B
cells, which showed little increase in M gene expression with time
(Figure 1C).
Protein expression of viral PB1 protein was barely detectable in
H1N1 virus infected BEAS-2B cells whereas corresponding
MDCK cells consistently showed much higher levels of PB1
(Figure 1D). Similarly, BEAS-2B cells released significantly less
(p,0.05) infectious virus than MDCK cells at 9, 24, 48 and 72 h
of infection (Figure 1E).
BEAS-2B and MDCK cells showed similar distribution of
human and avian influenza virus receptors
To determine if the cellular distribution of virus receptors on
BEAS-2B and MDCK cells could account for the difference in
viral replication between the two cell types, SA-linkage specific
lectin cytochemistry was performed. Similar co-expression of both
human (SAa2,6-Gal [green]) and avian (SAa2,3-Gal [red]) type
influenza virus receptors was found in BEAS-2B (Figure 2A) and
MDCK cells (Figure 2B), suggesting that there was no qualitative
difference in virus receptors between the two cell types.
BEAS-2B cells were more resistant than human primary
NHBE cells and human A549 cells to human H1N1 and
avian H2N3 influenza viruses
To compare the susceptibility of BEAS-2B cells with primary
NHBE and A549 cells, the three cell types were infected with
USSR H1N1 or avian H2N3 viruses at MOI of 1.0 (based on
MDCK cells). Viral NP at 6 h of infection with H1N1 virus
(Figure 3A) and H2N3 virus (Figure 3B) showed that few BEAS-
2B cells, most NHBE cells and virtually all A549 cells were positive
for viral NP. We then quantified viral M gene RNA expression
and progeny virus release in all three cell type at 10 and 24 h of
H1N1 virus infection. M gene expression (Figure 3C) and
infectious virus production (Figure 3D) from BEAS-2B cells were
significantly less than corresponding NHBE and A549 cells at 24 h
of H1N1 virus infection (p,0.05), with A549 cells showing the
highest M gene expression (Figure 3C) and infectious virus
production (Figure 3D).
BEAS-2B cells displayed differential accumulation of
human H1N1 and avian H2N3 viruses in extended
cultures
As BEAS-2B cells were more resistant to influenza virus
infection (Figures 1 and 3), they were infected with human
H1N1 and avian H2N3 viruses (at 1.0 MOI based on MDCK
cells) over an extended period of 72 h (Figure 4). At 6 h of
infection, there was little difference in virus accumulation as
determined by viral NP detection. However over 72 h of H2N3
virus infection, there was progressive increase in NP intensity and
number of infected cells (Figure 4B). Such changes were barely
detected in H1N1 virus infected BEAS-2B cells (Figure 4A). Thus,
virus accumulation in resistant BEAS-2B cells varied according to
virus subtype.
BEAS-2B cells showed high basal expression of IRF-7 and
several ISGs
To gain insight into the relative resistance of BEAS-2B cells to
H1N1 influenza virus infection, the basal expression of a selection
of genes associated with antiviral function was determined in the
three human epithelial cell types (BEAS-2B, NHBE and A549
cells) (Figure 5). In BEAS-2B cells, basal IRF-7 expression was
significantly higher than the other two cell types (p,0.05)
(Figure 5A). Notably, basal expression of STING (Figure 5D),
ISG15 (Figure 5E) andMx1 (Figure 5F) in BEAS-2B cells was also
significantly higher (p,0.05) than in NHBE and A549 cells.
BEAS-2B cells displayed strong induction of IRF-7 and
ISGs at 24 h of H1N1 virus infection
To evaluate the antiviral response to influenza virus, the three
human epithelial cell types were infected with the human H1N1
virus at 1.0 MOI (based on MDCK cells). In BEAS-2B cells at
10 h of infection, IRF-7 (Figure 6A), ISG15 (Figure 6C) and Mx1
(Figure 6D) expression were significantly down-regulated (p,0.05)
while STING expression (Figure 6B) was significantly up-regulated
(p,0.05); expression of IFN-b and IL-6 was unchanged (Figure 6
E–F). NHBE cells showed no significant change in antiviral gene
response, and in IFN-b and IL-6 expression at 10 h infection
(Figure 6E–F). In corresponding A549 cells, all antiviral genes
(except STING), IFN-b and IL-6 were significantly up-regulated
(p,0.05) (Figure 6A–F). By 24 h of infection, however, expression
of all four anti-viral genes and IFN-b and IL-6 was clearly up-
regulated (p,0.05) in all three cell types; BEAS-2B cells displayed
the highest expression of IRF-7, STING, Mx1 and IL-6.
JAK-STAT pathway inhibition increased susceptibility of
BEAS-2B cells to influenza virus infection
To assess the role of high basal and strong induced expression of
ISGs at 24 h of influenza virus infection, BEAS-2B cells were
treated with pyridine 6 (P6), a pan-JAK inhibitor known to shut
down ISG expression [24]. P6-treated BEAS-2B cells showed
Figure 6. BEAS-2B cells displayed strong induction of IRF-7 and several ISGs at 24 h of H1N1 virus infection. Human epithelial BEAS-2B,
NHBE and A549 cells were infected with human H1N1 virus at 1.0 MOI (based on MDCK cells). At 10 h of infection, expression pattern of antiviral
genes (A) IRF-7, (B) STING (C) ISG15, (D) Mx1, (E) IFN-b and (F) IL-6 was unremarkable in BEAS-2B and NHBE cells; however IRF-7, ISG15, Mx1, IFN-b and
IL-6 expression were up-regulated in A549 cells. Notably, all genes analyzed in BEAS-2B cells were significantly up-regulated by 24 h of infection;
BEAS-2B cells expressed the highest IRF-7, STING, Mx1 and IL-6 RNA amongst the three cell types. Data normalized to 18S rRNA expression. Data
points represent mean of 3 biological replicates. Error bar = SEM, *p,0.05.
doi:10.1371/journal.pone.0109023.g006
BEAS2B Cells Resistant to Influenza Virus Infection
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increased susceptibility to H1N1 virus infection as seen by greater
number viral NP positive cells at 6 h of infection compared with
DMSO controls (Figure 7A). BEAS-2B cells treated with P6
(2.5 mM) showed significantly higher (p,0.05) M gene RNA
(Figure 7B) and produced significantly (p,0.05) higher levels of
infectious progeny virus at 24 h of virus infection (Figure 7C). As
expected the expression of anti-viral genes namely IRF-7, IL-6,
Figure 7. Pan-JAK inhibitor P6 decreased ISG expression and increased susceptibility of BEAS-2B cells to H1N1 influenza virus
infection. (A) BEAS-2B cells treated with P6 inhibitor showed enhanced susceptibility to H1N1 influenza virus infection as evident by greater viral NP
expression in P6 treated cells compared with DMSO control. BEAS-2B cells were pre-treated with P6 at a final concentration of 2.5 or 5 mM for 24 h
and infected with H1N1 influenza virus at 1.0 MOI (based on MDCK cells). At 6 h post-infection cells were immunostained for viral NP. (B) P6 treated
(2.5 mM) BEAS-2B cells showed higher influenza M gene RNA expression and (C) produced higher levels of infectious progeny virus at 24 h of H1N1
influenza virus infection. Increased influenza virus replication in P6 treated BEAS-2B cells corresponded to decreased expression of (D) IRF-7 (E) IL-6 (F)
ISG15 (G) STING (H) Mx1 compared with the controls. Total RNA extracted at 24 h infection from P6 or DMSO pre-treated cells was used for gene
expression analysis re normalized to 18S rRNA expression. Culture supernatants collected at 24 h virus infection from P6 or DMSO pre-treated cells
were subjected to infectious virus titration on MDCK cells using an immunocytochemical focus assay. Data points represent mean of 3 biological
replicates with error bars showing standard deviation, *p,0.05.
doi:10.1371/journal.pone.0109023.g007
BEAS2B Cells Resistant to Influenza Virus Infection
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ISG15, STING and Mx1 was significantly reduced in P6 treated
BEAS-2B cells.
Discussion
In this study, BEAS-2B cells were shown to be significantly
resistant to avian H2N3 and human H1N1 IAV infection
compared with MDCK, NHBE and A549 cells. Influenza virus
PB1 protein is an essential subunit of influenza virus RNA
polymerase and plays a key role in influenza virus replication [26].
Poor replication of influenza viruses in BEAS-2B cells was
associated with little PB1 protein expression in contrast to
corresponding abundance of PB1 in MDCK cells. Viral HA
binding to host SA receptors initiates IAV replication and the
specific SA receptor distribution pattern of cells determines IAV
susceptibility [20]. We found similar patterns of co-expression of
avian and mammalian type influenza receptors in BEAS-2B and
MDCK cells, which indicated that the resistance of BEAS-2B cells
was not due to the absence of specific virus receptors.
Comparison of the kinetics of IAV replication showed that
BEAS-2B cells were also highly resistant to IAV replication
compared with the NHBE and A549 cells. In contrast to our
findings, an earlier study found similar viral PB1 gene expression
between BEAS-2B and A549 cells [27]. The reason for this
difference is not clear, however the previous finding used different
influenza virus strains, i.e. A/Udorn/72 (H3N2) and A/WSN/33
(H1N1), and the results were based on qRT-PCR quantification of
PB1 gene expression rather than PB1 protein expression and
infectious virus release. Thus it is possible that the choice of virus
strains or a difference in the methodology may be responsible for
the different observations.
Influenza virus replication in cell cultures can be different
depending on the origin of influenza viruses. For example, human,
avian and swine influenza viruses showed different replication
kinetics in NHBE cells with human IAVs growing to higher titres
[28]. In contrast, we found that BEAS-2B cells were relatively
more resistant to human H1N1 than avian H2N3 influenza virus
infection. These findings suggest that BEAS-2B cells do not reflect
the natural host restriction pattern of NHBE cells to IAV infection.
In order to establish the molecular basis for the IAV resistance
in BEAS-2B cells, we evaluated the regulation of antiviral
pathways before and after H1N1 virus infection. We found
significantly higher basal expression of IRF-7 in BEAS-2B cells
compared with NHBE and A549 cells. IRF-7 plays a key role in
mediating host resistance against influenza virus replication. For
example, IRF-7 knockdown resulted in enhanced PR8 influenza
virus production in A549 cells and MDCK cells [29]. This study
also found high basal expression of key antiviral genes namely
STING, ISG15 and Mx1 in BEAS-2B cells relative to NHBE and
A549 cells. ISG15 is one of the most highly induced IFN-induced
proteins and inhibits replication of a wide range of viruses
including IAVs [30]. High basal expression of Mx is also a key
marker of virus resistance in cells. For example, vesicular stomatitis
virus (VSV) resistant human pancreatic ductal adenocarcinoma
(PDA) cell lines displayed high basal expression of ISGs MxA and
29,59-oligoadenylate synthetase (OAS) in comparison with VSV
susceptible PDA cells [31]. STING plays an important role in host
defence against a range of intra-cellular pathogens and acts as a
cytosolic DNA sensor [32]. The collective evidence suggests that
resistance of BEAS-2B cells to IAV infection is mediated by high
basal expression of antiviral genes and their subsequent strong
induction (by 24 h) in response to infection. Furthermore, high
basal expression of cytosolic DNA sensor STING in BEAS-2B cells
raises the possibility that these cells could also be resistant to DNA
viruses. Hence, it is prudent to determine the susceptibility of
BEAS-2B cells to other viruses to assess its usefulness as an in vitro
model for the study of virus cytopathogenesis.
Distinct profiles of antiviral gene responses following IAV
infection were also noticed among the three respiratory epithelial
cells (BEAS-2B, NHBE and A549 cells). In particular, the
regulation of antiviral genes at 10 h of virus infection was highly
variable among the cell types. Notably, A549 cells showed
significantly higher expression of IFN-b and IL-6 expression than
BEAS-2B and NHBE cells at 10 h of infection. This could be due
to higher levels of IAV replication in A549 cells compared with
other cells. IL-6 is a vital innate immune cytokine in the protection
against severe influenza A infection [33]. IL-6 induction was
highest in A549 cells at 10 h of infection, while it was highest at
24 h of infection in BEAS-2B and NHBE cells. While we do not
know the significance of the distinct cytokine expression profiles
among the three cells, clearly there were inherent differences in
IAV cytopathogenesis in these cells. It is well recognised that
inhibition of JAK/STAT signalling results in reduced ISG
expression [31]. We showed that JAK/STAT inhibition by P6
treatment reversed the antiviral state of BEAS-2B cells as evident
by the lower mRNA level of ISGs. Enhanced susceptibility of P6
treated BEAS-2B cells to IAV infection is evident from increased
viral M gene RNA detection and increased production of
infectious progeny virus.
In conclusion, comparison of IAV replication in three human
respiratory epithelial cell types along with MDCK cells showed
BEAS-2B cells to be highly resistant to avian H2N3 and human
H1N1 IAV infection. Resistance of BEAS-2B cells to H1N1 virus
was mediated by high basal expression of antiviral genes namely
IRF-7, STING, ISG15 and Mx1. JAK/STAT inhibition by P6
treatment reversed the antiviral state of BEAS-2B cells and
resulted in increased H1N1 virus replication. Studies continue to
make inferences on IAV pathogenesis based on results of infected
BEAS-2B cells [27,34,35]. However, it is clear from our data that
IAV replication and host response in BEAS-2B cells are different
from primary NHBE cells. Our findings warrant evaluation of
BEAS-2B cells for suitability for use with other human respiratory
viruses. This study highlights the importance of using appropriate
cell culture models that closely reflect viral pathogenesis in a given
host species to make valid inferences.
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